Article Summary
谢 田,孙 侃,张 松,翟 力,庞硕勋,耿立兴.薛氏4号方联合苯磺酸氨氯地平片治疗湿热侵络型高血压的疗效及对血脂和血液流变学的影响[J].现代生物医学进展英文版,2024,(1):148-151.
薛氏4号方联合苯磺酸氨氯地平片治疗湿热侵络型高血压的疗效及对血脂和血液流变学的影响
Efficacy of Xueshi No.4 Recipe Combined with Amlodipine Besylate Tablet in the Treatment of Hypertension of Damp Heat Invading Collaterals and Its Effect on Blood Lipids and Hemorheology
Received:June 06, 2023  Revised:June 28, 2023
DOI:10.13241/j.cnki.pmb.2024.01.029
中文关键词: 薛氏4号方  苯磺酸氨氯地平片  湿热侵络型高血压  疗效  血脂  血液流变学
英文关键词: Xueshi No.4 recipe  Amlodipine besylate tablet  Hypertension of damp heat invading collaterals  Efficacy  Blood lipids  Hemorheology
基金项目:河北省中医药管理局中医药类科研计划项目(2020340)
Author NameAffiliationE-mail
谢 田 石家庄市中医院中医心内科 河北 石家庄 050051 13703212650@163.com 
孙 侃 石家庄市中医院中医心内科 河北 石家庄 050051  
张 松 石家庄市中医院中医心内科 河北 石家庄 050051  
翟 力 石家庄长城中西医结合医院内科 河北 石家庄 050035  
庞硕勋 石家庄长城中西医结合医院内科 河北 石家庄 050035  
耿立兴 京东中美医院中医内科 河北 廊坊 065201  
Hits: 434
Download times: 289
中文摘要:
      摘要 目的:观察湿热侵络型高血压患者经苯磺酸氨氯地平片联合薛氏4号方治疗后的疗效及其对血脂和血液流变学的影响。方法:采用随机数字表法将2020年1月~2022年12月期间石家庄市中医院收治的120例湿热侵络型高血压患者分为对照组(n=60,苯磺酸氨氯地平片治疗)及联合组(n=60,对照组基础上接受薛氏4号方治疗)。观察两组治疗4周后的临床疗效,对比两组治疗前、治疗4周后的血压、中医证候积分、血脂和血液流变学情况。结果:联合组的临床总有效率高于对照组(P<0.05)。联合组治疗4周后收缩压(SBP)、舒张压(DBP)低于对照组(P<0.05)。联合组治疗4周后眩晕、头痛、口渴少饮、肢体困重、失眠、心悸、胸闷、肢体麻木中医证候积分低于对照组(P<0.05)。联合组治疗4周后甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)低于对照组,高密度脂蛋白胆固醇(HDL-C)高于对照组(P<0.05)。联合组治疗4周后红细胞聚集指数、血小板最大聚集率、全血高切黏度、全血低切黏度低于对照组(P<0.05)。结论:薛氏4号方联合苯磺酸氨氯地平片治疗湿热侵络型高血压,可提高临床疗效,降低血压,降低中医证候积分,改善血脂和血液流变学。
英文摘要:
      ABSTRACT Objective: To observe the curative effect of Amlodipine besylate tablets combined with Xueshi No.4 recipe and its effect on blood lipids and Hemorheology in patients with hypertension of dampness heat invading collaterals. Methods: 120 patients with damp heat collateral invasion hypertension admitted to Shijiazhuang Traditional Chinese Medicine Hospital from January 2020 to December 2022 were divided into the control group (n=60, treated with Amlodipine besylate tablets) and the combined group (n=60, treated with Xueshi No.4 recipe on the basis of the control group) by random number table. The clinical efficacy in two groups 4 weeks after treatment was observed, the blood pressure, traditional Chinese medicine syndrome scores, blood lipids and hemorheology before treatment and 4 weeks after treatment were compared between two groups. Results: The clinical total effective rate in combined group was higher than that in control group(P<0.05). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) in combined group at 4 weeks after treatment were lower than those in control group(P<0.05). The traditional Chinese medicine syndrome scores of vertigo, headache, thirst and lack of drinking, limb fatigue, insomnia, palpitations, chest tightness,and limb numbness in combined group at 4 weeks after treatment were lower than those in control group(P<0.05). The triglyceride (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in combined group at 4 weeks after treatment were lower than those in control group, while high-density lipoprotein cholesterol (HDL-C) in combined group at 4 weeks after treatment was higher than those in control group (P<0.05). The erythrocyte aggregation index, maximum platelet aggregation rate, whole blood high shear viscosity, and whole blood low shear viscosity in combined group at 4 weeks after treatment were lower than those in control group(P<0.05). Conclusion: Xueshi No.4 recipe combined with amlodipine besylate tablet in the treatment of hypertension of damp heat invading collaterals, which can improve clinical efficacy, reduce blood pressure, reduce traditional Chinese medicine syndrome scores, and improve blood lipids and hemorheology.
View Full Text   View/Add Comment  Download reader
Close